Rabies Virus Glycoprotein TFA

Rabies Virus Glycoprotein TFA, an absolutely pivotal pharmaceutical constituent, is extensively applied in manufacturing vaccines that specifically combat the ruthless manifestations resulting from infections caused by the rabies virus. By effectively enabling the initiation of protective immunological reactions targeting the viral glycoprotein, this extraordinary entity plays a paramount role in mitigating and managing the dire consequences associated with the pernicious rabies affliction.

Online Inquiry

Specification Technical Data Related Products Featured Products Customer reviews and Q&A Useful Tools Publications

CAT#	GR2201
M.F/Formula	C143H218N43F3O45S
M.W/Mr.	3380.72
Appearance	Solid

CAT#	Product Name	Inquiry
GR2148	11R-VIVIT TFA	Inquiry
GR1502	Mastoparan 7	Inquiry
GR2164	Gly-Arg-Gly-Asp-Ser TFA	Inquiry
GR2230	CPP2	Inquiry
GR2173	KLA seq	Inquiry

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-20	Goserelin Acetate	1269.43	C59H84N18O14	Inquiry
10-101-59	Liraglutide	3751.2	C172H265N43O51	Inquiry
R1574	Octreotide	1019.24	C₄₉H₆₆N₁₀O₁₀S₂	Inquiry
10-101-139	Myrcludex B			Inquiry
10-101-285	Teduglutide	3752.08	C164H252N44O55S	Inquiry
R1847	Sermaglutide	4114	C187H291N45O59	Inquiry
R1961	Carbetocin	988.2	C45H69N11O12S	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.